highly significantp = 0.0001
Quantification of GS-IB4 and CD31 CNV area demonstrated a highly significant reduction in the median lesion area of 45.6 [27.1–59.4]% ( p = 0.0001) and 45.1 [24.3–60.2]% ( p = 0.0006), respectively, in 13-12AB-PEDF-injected eyes compared with S1-S2AB-AsRed-injected control eyes ( Figures 5 B–5D).